Transcatheter embolization therapy in liver cancer
Publication in refereed journal

香港中文大學研究人員
替代計量分析
.

其它資訊
摘要Embolization procedure is commonly used in interventional oncology. Transarterial chemoembolization (TACE) has been shown to provide a survival benefit for liver cancer patients. TACE combines targeted chemotherapy with the effect of ischemic necrosis induced by arterial embolization. Recently, there have been efforts to improve the delivery of chemotherapeutic agents to tumors, leading to the development of drug-eluting particles. To avoid the limitation of external beam irradiation due to the radiosensitive nature of normal hepatic tissue, minimally invasive transarterial radioembolization (TARE) technique has been developed, and proven to be safer in advanced liver cancers. This review describes the basic procedure of transarterial chemoembolization, properties and efficacy of some chemoembolization agents and radioembolization agents which are commercially available and/or currently under clinical evaluation. The key clinical trials of transcatheter arterial therapy for liver cancer and the recent patents relevant to cancer chemoembolization are also summarized. © 2012 Bentham Science Publishers.
著者Wang Y.-X.J.
期刊名稱Recent Patents on Medical Imaging
出版年份2012
月份12
日期4
卷號2
期次2
出版社Bentham Science Publishers
出版地United Arab Emirates
頁次150 - 162
國際標準期刊號2210-6847
語言英式英語
關鍵詞Chemoembolization, Drug-eluting particles, Hepatocellular carcinoma, Lipiodol, Microspheres, Radioembolization, Transarterial, Yttrium-90

上次更新時間 2021-11-01 於 00:57